News and Events

Tempus and Feist-Weiller Cancer Center at LSU Health Shreveport Announce Brain Cancer Research Collaboration

Chicago, April 29 – Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced a new research collaboration with the Feist-Weiller Cancer Center at LSU aimed at improving outcomes for patients battling brain cancer.

As part of this research study, Tempus will work directly with Dr. Maria-Magdalena Georgescu, M.D., P.h.D. Dr. Georgescu studies patients diagnosed with glioblastoma (GBM), the most common and deadly primary brain tumor, and also patients diagnosed with metastatic disease to the brain who are unlikely to respond to conventional therapies, mainly due to breast cancer and NSCLC.

In this partnership, Tempus will perform genomic sequencing and clinical data structuring for the patients, while LSU Health Shreveport will provide de-identified clinical data to be matched to the molecular data that is generated. Utilizing machine learning and advanced bioinformatics, Tempus will analyze these new data sets in a search for potentially relevant patterns of clinical progression and response to therapy in these patients battling cancer.

Glioblastomas and DIPGs are highly malignant neoplasms that grow and invade normal brain quickly, leaving healthcare providers with limited options. For both adults and children with these tumors, the median survival is approximately 15 months. The existing approaches to treat GBM patients are not sufficient, and a comprehensive data set is needed to link patient characteristics and outcomes to ultimately identify a better path forward.

At LSU Health Shreveport & The Feist-Weiller Cancer Center, our mission is to reduce the impact of cancer in our community,” said Dr. Georgescu. “Working with Tempus allows our researchers to access analytics and tools that enable them to better understand the molecular composition of these patients’ tumors and how their genomic profile relates to therapy targets, therapy response, and outcome.”

The collection of clinical and molecular data is key to efforts to understand cancer,” said Eric Lefkofsky, Founder and CEO at Tempus. “As we continue to work hand-in-hand with hospital systems such as the LSU Health Shreveport & The Feist-Weiller Cancer Center and grow our understanding of cancer that is affecting the brain, we hope to uncover patterns of clinical significance that will benefit patients diagnosed with this often lethal disease.”

Tempus is currently working with a number of academic centers and hospital systems on GBM related research initiatives, including Case Comprehensive Cancer Center at Case Western Reserve University, Duke University School of Medicine and Huntsman Cancer Institute at the University of Utah. In addition, Tempus continues to work with clinicians across the country who treat patients diagnosed with GBM.

LSU Health Research Ranking

LSU Health - Shreveport is excited to annouce we are ranked #46 nationally and #1 in Lousiana in medical research funding by Blue Ridge Institute for Medical Research (BRIMR).

Click here for more information

LSU Health Pathology At USCAP 2019

March 16 - 21th, 2019, LSU Health Pathology will host and exhibit at 2019 USCAP at the National Harbor, Maryland. LSU Health will be at booth #225 in the Exhibit Hall. 

Click here for more information

39th Annual William R. Mathews Lecture Pathology

September 26 - 27th, 2019, LSU Health Pathology will host Dr. Barbara Ducatman as she reviews interesting cases. 

Thursday, September 26, 2019 @ 6:30 PM – East Ridge Country Club, 1000 Stewart Drive, Shreveport LA.  Social, Dinner & Seminar – (topic TBA)

Friday, September 27, 2019 at LSUHSC Pathology Department

9:00 AM - 1-hour slide conference with residents and fellows at LSUHSC

10:15 AM - W.R. Mathews Lecture—Topic TBA

LSU Health Pathology At ASN Kidney Week 2018

October 23 - 28th, 2018, LSU Health Pathology will host and exhibit at 2018 ASN Kidney Week in San Diego, California. LSU Health will be at booth #1135 in the Exhibit Hall. 

Click here for more information

Dr. William R. Mathews - 38th Annual Lecture in Pathology

On September 27 - 28th, 2018, LSU Health Shreveport will host Dr. Allen Gown as he reviews interesting cases in Medical School Room 2-305. Dr. Gown is recognized as one of the world's leading experts in diagnostics and research applications of immunohistochemistry (IHC).

Click here for more information

$10.5 Million NIH COBRE Grant Awarded to LSU Health Shreveport

LSU Health Shreveport has been awarded a five-year, $10.5 million Centers of Biomedical Research Excellence (COBRE) grant by the National Institutes of Health. The current grant raises the total NIH funding to the Pathology Department to $3.7 million in annual funding, which would rank #1 in the state of Louisiana and #41 in the country based on the current rankings.

For more information click here

LSU Pathologists and Researchers Co-author Monoclonal Immunoglobulin-related Renal Diseases Article

On February 19th 2018, Drs. Guillermo Herrera, Jiamin Teng, & Elba Turbat-Herrera, in collobaration with several other outside clinicians and researchers, published an article on monoclonal immunoglobulin-related renal diseases in Nature Reviews Nephrology.

Click here to read the publication

LSUHSC Division of Research Earns 20 Impact Score for COBRE

Roles for Pathology Faculty in the COBRE application:

Christopher Kevil, COBRE Principle Investigator
A. Wayne Orr, Core Leader, Redox Molecular Signaling Core
Shenuarin Bhuiyan, Subcore Leader, Cardiovascular Phenotyping Subcore
Xinggui Shen, Subcore Leader, Analytical Redox Biology Subcore


Pending (20 Impact Score)

Project Number/PI/Role

C.G. Kevil, PI


National Institute of General Medical Sciences, COBRE

Title of Project (and/or Subproject):

Center for Redox Biology and Cardiovascular Disease

The overall objectives of the COBRE Center for Redox Biology and Cardiovascular Disease are to establish a nationally recognized advanced research and training program in redox biology regulation of cardiovascular disease and to facilitate the development of junior faculty research programs to achieve major independent research funding.

LSUHSC Pathology Abstract Presentations for USCAP 2018

LSU Health Sciences Center Department of Pathology submitted a total of 11 abstracts for USCAP in Vancouver, BC March 17-23, 2018; remarkably all but two were accepted.  Please click the following link for a complete list of titled abstracts and their respective authors:

Abstracts USCAP 2018

LSU Health Sciences Center and the Department of Pathology Welcomes Dr. Juan Mercado

Dr. Mercado comes to us from the University of Alabama at Birmingham (UAB) where he completed his Fellowship and is now the second Neuromuscular Pathologist to join our department.  For further information on Dr. Mercado please click here: Dr. Juan Mercado

2018 USCAP Annual Meeting

March 17-23, 2018 – Vancouver Convention Centre – Vancouver, BC, Canada

Click here to learn more

Research Seminar Calendars

2017-2018 LSU Department of Pathology Research Seminar Series Calendar

37th Annual William R. Mathews Lecture in Pathology

Invited Speaker: Mark Robert Wick, MD

Schedule of Events:
Thursday, September 28, 2017 - 6:30 pm - Dinner and Seminar
"The history of adjunctive techniques in anatomic pathology, before molecular era"
East Ridge Country Club

Friday, September 29, 2017 - 10:00 am - Lecture
"The diagnosis of 'early' lung cancer - a pathobiological perspective"
LSU Health Shreveport, Medical School Room 3-322

RSVP - Jessica Torre - (318) 675-4557

Click here to learn more

Rare Neuroendocrine Breast Cancer Not So Unusual

CHICAGO — A rare neuroendocrine carcinoma of the breast might not be as uncommon as has generally been believed and can be missed unless stained specifically for neuroendocrine markers, new research suggests.

"Some of the cases we picked up just looked like high-grade ductal carcinoma, and there was no clear neuroendocrine differentiation in some of the tumors we are reporting on," said investigator Lubna Alattia, MD, a resident at Louisiana State University Health Sciences Center Shreveport.

Click here to learn more


  • Shoujun Chen, MD, PhD, Pathology Resident, received Second Place for Excellence in Research for his project “The Use of Selective Engagement Assays to Discern the Function of Syndecans in Podocytes” at the Annual Albert G. Smith Research Forum on June 2nd.
  • Valerie Lockhart, MD, MBA, Pathology Chief Resident, received Third Place for Excellence in Research for her project “Ordering, Reporting, and Billing of Immunohistochemical Stains in Copath at a Single Institution: A Quality Assurance Study” at the Annual Albert G. Smith Research Forum on June 2nd.
  • A. Wayne Orr, PhD, Professor of Pathology, Physiology, Cellular Biology & Anatomy, was selected to serve on the National Institutes of Health’s Vascular Cell and Molecular Biology Study Section.  His six-year appointment began July 1st.
  • Roberto Silva, MD, Pathology Resident, received the Annual Resident In-service Exam Award for placing in the 99th percentile.
  • Hongzhi Xu, MD, PhD, Pathology Resident, received Second Place for Excellence in Research for his project “Phagocytotic Activity of Mesenchymal Stem Cells (MSCs) is an Important Mechanism in Repairing the Damaged Mesangium” at the Annual Albert G. Smith Research Forum on June 2nd.


  • Elba A. Turbat-Herrera, MD, Professor of Pathology: “Understanding Renal Pathology.  The Normal Kidney.  Light, Immunofluorescence and Ultrastructural Correlates,” Mount Sinai Medical Center in Miami Beach, FL May 22nd.
  • Guillermo A. Herrera, MD, Albert G. and Harriet G. Smith Professor and Chair of Pathology: “New Concepts in Monoclonal Gammopathies of Renal Significance (MGRS): The Role of the Pathologist,” Northshore Hospital, St. Petersburg, FL May 18th; “How Free Serum Light Chains Testing Has Changed the Renal Pathologist’s Practice: Clinical Implications,” Tampa, Florida, May 18th; “Generic Renal Responses/Speciation of Renal Pathological Lesions: How Light, Immunofluorescence and Electron Microscopy Come Together in the Clinical Context of Patients with Renal Disorders,” Mount Sinai Medical Center, Miami Beach, FL May 22nd.


Alexandra C. Finney, BS, PhD Candidate and Graduate Research Assistant; Steven D. Funk, PhD, Pathology; Jonette Green, BS, Pathology Research Associate; Arif Yurdagul Jr., PhD, Pathology; Mohammad A. Rana, MD, Cardiology Fellow; Rebecca Pistorius, MD, Pathology Resident; Miriam Henry, BS, Medical Student; Andrew D. Yurochko, PhD, Professor of Microbiology & Immunology; Christopher B. Pattillo, PhD, Assistant Professor of Physiology; James G. Traylor, MD, Associate Professor of Pathology; Matthew D. Woolard, PhD, Associate Professor of Microbiology & Immunology; Christopher G. Kevil, PhD, Vice Chancellor of Research; A. Wayne Orr, PhD: “EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis,” Circulation, May 9th.